Title : Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis - Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
Author(s) : Chai S , Zhang R , Zhang Y , Carr RD , Zheng Y , Rajpathak S , Ji L |
Ref : Front Endocrinol (Lausanne) , 13 :994944 , 2022 |
Abstract : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
ESTHER : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
PubMedSearch : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
PubMedID: 36313782 |
Chai S, Zhang R, Zhang Y, Carr RD, Zheng Y, Rajpathak S, Ji L (2022)
Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
Front Endocrinol (Lausanne)
13 :994944
Chai S, Zhang R, Zhang Y, Carr RD, Zheng Y, Rajpathak S, Ji L (2022)
Front Endocrinol (Lausanne)
13 :994944